ACRA CCCC
$45.11 1.11 2.46%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 14 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

3.09B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

2.97B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

-
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

68.43M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-

Upcoming events

All events
No upcoming events scheduled

Stock chart

Stock analysis

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

-24.49 -
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

12.54 3.92
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

-22.74 -
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

0.93 -
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

-48.81 -

Price change per year

23.63$ 51.21$
Min Max

Summary analysis

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure

Revenue and net income

All parameters

Stock news

All news

Налоговики оспорили в суде РФ вывод из страны 12,9 млрд р в пользу Ikea

Транзит в КНР по Севморпути к 2030 году может вырасти в 20 раз - глава Росатома

"Русхимальянс" подал кассацию на решение суда по запрету Linde судиться за рубежом

Суд РФ арестовал активы Deutsche Bank по иску Русхимальянса

Бум IPO далек от завершения: как компании готовятся к публичности

Кабмин РФ включил Оренбургскую область в программу стимулирования занятости

Суд РФ наложил арест на активы и счета Deutsche Bank по иску "Русхимальянса"

СУД РФ НАЛОЖИЛ АРЕСТ НА АКТИВЫ, СЧЕТА И ИМУЩЕСТВО DEUTSCHE BANK ПО ИСКУ "РУСХИМАЛЬЯНСА" - КАРТОТЕКА

"Газпром" подает газ для Европы через Украину в объеме 42,4 млн куб. м через "Суджу"

When branding goes bad: the lessons from the Co-op Live crisis

Россия отправила в Китай первый поезд экспортного сервиса "Мясной шаттл"

Тверь направит представителя в торгпредство РФ в Пекине для сотрудничества с КНР

About company

C4 Therapeutics, Inc., a biopharmaceutical company, develops novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable degrader that is in preclinical stage targeting IKZF1/3 for multiple myeloma and non-Hodgkin lymphomas, including peripheral T-cell lymphoma and mantle cell lymphoma. The company is also developing CFT8634, an orally bioavailable degrader of BRD9, a protein target for synovial sarcoma and SMARCB1-deleted solid tumors; and BRAF V600E to treat melanoma, non-small cell lung cancer, colorectal cancer, and other solid malignancies, as well as RET to treat lung cancer, sporadic medullary thyroid cancers, and other solid malignancies. C4 Therapeutics, Inc. has strategic collaborations with F. Hoffman-La Roche Ltd.; Biogen, Inc.; and Calico Life Sciences LLC. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
Address:
490 Arsenal Way, Watertown, MA, United States, 02472
Company name:
Issuer ticker: CCCC
ISIN: US12529R1077
Country: USA
Exchange: ACRA
Currency: $
IPO date: 2020-10-02
Sector: Healthcare
Industry: Biotechnology
Site: https://www.c4therapeutics.com

On which stock exchange are (CCCC) stocks traded?

(CCCC) stocks are traded on ACRA.

What is the ticker of stocks (CCCC)?

The stock ticker of ’s stocks or in other words, the code is CCCC. The stocks are currently listed on the ACRA exchange.

In which sector and industry does (CCCC) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, (CCCC) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are (CCCC) stocks traded?

(CCCC) stocks are traded on the ACRA exchange in dollars.

What is the price of (CCCC) stocks today?

The current price of stocks on 18.05.2024 is 45.11 dollars. per share.

What is the dynamics of (CCCC) stocks from the beginning of the year?

(CCCC) quotes have increased by 0% from the beginning of the year up to 45.11 dollars. per 1 stocks.

How much did (CCCC) stocks increase in мае 2024?

This month (CCCC) quotes have increased by 0% to 45.11 dollars. per share.

How much are (CCCC) stocks worth?

Today, on October, 18.05.2024 ’s (CCCC) stocks cost 45.11 dollars..

What is the market capitalization of (CCCC)?

Capitalization is the market value of (CCCC) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 18.05.2024, the market capitalization of (CCCC) is estimated at about 3086975098 dollars.